Table 2.
Clinicopathologic data for the 98 pancreatic tissue donors. Grade, tumor status, nodal status, and metastasis are taken from the 46 carcinoma samples.
| Characteristics | Donors |
Characteristics | Donors |
||||
|---|---|---|---|---|---|---|---|
| N | (%) | N | (%) | ||||
| Age | Grade | ||||||
| ≤ 53 | 41 | 41.8 | 1 | 8 | 17.4 | ||
| > 53 | 57 | 58.2 | 2 | 15 | 32.6 | ||
| Sex | 3 | 13 | 28.3 | ||||
| Male | 57 | 58.2 | Not determined | 10 | 21.7 | ||
| Female | 41 | 41.8 | Tumor status | ||||
| Histology | 1 | 2 | 4.3 | ||||
| Adenosquamous carcinoma | 3 | 3.1 | 2 | 27 | 58.7 | ||
| Chronic inflammation | 2 | 2.0 | 3 | 14 | 30.4 | ||
| Chronic pancreatitis | 2 | 2.0 | 4 | 2 | 4.3 | ||
| Duct adenocarcinoma | 42 | 42.9 | Not determined | 1 | 2.2 | ||
| Hyperplasia | 2 | 2.0 | Nodal status | ||||
| Islet cell carcinoma | 1 | 1.0 | 0 | 36 | 78.3 | ||
| Islet cell tumor | 10 | 10.2 | 1 | 8 | 17.4 | ||
| Mild chronic inflammation | 6 | 6.1 | Not determined | 2 | 4.3 | ||
| Type | Metastasis | ||||||
| Normal | 10 | 10.2 | 0 | 42 | 91.3 | ||
| NAT | 20 | 20.4 | 1 | 3 | 6.5 | ||
| Benign | 10 | 10.2 | Not determined | 1 | 2.2 | ||
| Hyperplasia | 2 | 2.0 | |||||
| Inflammation | 10 | 10.2 | |||||
| Malignant | 46 | 46.9 | |||||